Lanean...

Allogeneic transplantation in elderly patients ≥65 years with non-Hodgkin lymphoma: a time-trend analysis

Allogeneic hematopoietic cell transplantation (allo-HCT) is a curative therapy for relapsed/refractory and high-risk non-Hodgkin lymphoma (NHL). However, no large studies have evaluated allo-HCT utilization in elderly NHL patients (≥65 years). Using the CIBMTR registry, we report a time-trend analys...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Blood Cancer J
Egile Nagusiak: Shah, Nirav N., Ahn, Kwang Woo, Litovich, Carlos, Sureda, Anna, Kharfan-Dabaja, Mohamed A., Awan, Farrukh T., Ganguly, Siddhartha, Gergis, Usama, Inwards, David, Karmali, Reem, Lazaryan, Alexsandr, Lekakis, Lazaros, Munshi, Pashna, Nathan, Sunita, Saad, Ayman A., Solh, Melhem, Steinberg, Amir, Vij, Ravi, Wood, William A., Fenske, Timothy S., Smith, Sonali, Hamadani, Mehdi
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group UK 2019
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6890709/
https://ncbi.nlm.nih.gov/pubmed/31796726
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-019-0261-1
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!